Clinical Trials Logo

Health-Related Quality of Life clinical trials

View clinical trials related to Health-Related Quality of Life.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04881097 Withdrawn - Sepsis Clinical Trials

Cognitive Function and Health-related Quality of Life After Neuro-intensive Care

COGNI
Start date: August 1, 2021
Phase:
Study type: Observational

The study will provide information on cognitive impairment and Health related quality of life in patients surviving 12 months after acute brain injury, generate a hypothesis of useful variables to predict cognitive impairment or low levels of HRQoL, and potentially inform interventions for the prevention and treatment of cognitive impairment following neuro-ICU stay.

NCT ID: NCT03173794 Withdrawn - Clinical trials for Patient Satisfaction

CommunityRx for Hunger: A Hospital-Based Intervention

Start date: April 2018
Phase: N/A
Study type: Interventional

The goal of this research program is to reduce health disparities by deploying an information-based intervention to increase caregiver utilization of community-based food supports and satisfaction with care among food insecure caregivers of hospitalized children. We will conduct a randomized controlled trial to evaluate, versus usual care, the effects of the CommunityRx-H intervention on caregiver use of food resources (primary), caregiver patient satisfaction with care (primary), caregiver mental health-related quality of life (secondary), and caregiver household food security (secondary). The proposed research will yield an understanding of how to leverage a child's hospitalization to effectively intervene on the problem of food insecurity. Findings will inform the rapidly growing field of healthcare-based interventions to address health-related social needs.

NCT ID: NCT01573806 Withdrawn - Inflammation Clinical Trials

Pharmacology of Exenatide in Pediatric Sepsis

PEPS
Start date: October 2012
Phase: Phase 1/Phase 2
Study type: Interventional

Pharmacology of Exenatide in Pediatric Sepsis, PEPS is a phase 1-2 research study that will examine drug safety, drug metabolism, drug action and preliminary drug clinical effects of four does of exenatide injected every 12 hours to children with shock from infection (septic shock). The investigators hypothesize that exenatide can be safely dosed to children with sepsis to achieve blood levels of drug similar to that achieved in teenagers with type 2 diabetes. The investigators further hypothesize that injection of exenatide to children with septic shock will normalize blood glucose levels and decrease levels of inflammation proteins in the blood during the early course of sepsis.